Fluidigm Corp (FLDM) 43.04 $FLDM Thermo Fisher Q1

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:40 PM

Fluidigm Corp (FLDM) 43.04 $FLDM

Thermo Fisher Q1 Earnings Top, Revenues Lag Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 11:10AM CDT
Thermo Fisher Scientific, Inc. (TMO) reported its first-quarter 2015 financial results.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), TMO: 130.69 (-3.75), LMNX: 16.34 (-0.01)

Inogen Gains despite Further Delay in Form 10-K Filing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 10:50AM CDT
Shares of Inogen Inc. (INGN) climbed nearly 2.4% following the announcement that it needs additional time to file its Annual Report on Form 10-K for the year ended Dec 31, 2014.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01)

Thoratec Hits 52-Week High on Favorable Developments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 10:20AM CDT
Shares of Thoratec Corp (THOR) scaled a new 52-week high of $43.24 in mid-day trading on Apr 15.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), THOR: 43.00 (-0.76)

Masimo to Launch Patient SafetyNet System with Iris, MyView - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 12:10PM CDT
Masimo Corp (MASI) announced the launch of Patient SafetyNet Series 5000 at the HIMSS Annual Conference and Exhibition in Chicago.
ABMD: 69.31 (-0.40), MASI: 34.96 (+0.43), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04)

qPCR and dPCR Instrumentation Market: Educational/Research, Testing Laboratories, Pharmaceuticals - Global Strategic Business Report
M2 - Tue Apr 14, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tg6qrs/qpcr_and_dpcr) has announced the addition of the "qPCR and dPCR Instrumentation - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousands by the following Product Segments: qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction). Also, the report analyzes the following End-Uses: Educational/Research, Testing Laboratories, Pharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 41 companies including many key and niche players such as: - Agilent Technologies, Inc. (US) - Becton, Dickinson and Company (US) - BioFire Diagnostics, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - Cepheid (US) - Eppendorf AG (Germany) - Exiqon A/S (Denmark) - F. Hoffmann-La Roche Ltd. (Switzerland) - Fluidigm Corporation (US) - Illumina, Inc. (US) - Promega Corporation (US) - RainDance Technologies, Inc. (US) - QIAGEN N.V. (Netherlands) - Takara Bio, Inc. (Japan) - Thermo Fisher Scientific Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. GROWTH DRIVERS, MARKET TRENDS & ISSUES 3. COMPETITION 4. END-USE MARKET ANALYSIS 5. PRODUCT OVERVIEW 6. INSIGHT INTO GLOBAL SPENDING ON LIFE SCIENCES RESEARCH 7. PRODUCT INNOVATIONS/INTRODUCTIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT GLOBAL PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 41 (including Divisions/Subsidiaries (44) - The United States (26) - Canada (1) - Japan (1) - Europe (15) - Germany (5) - The United Kingdom (2) - Spain (1) - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/tg...r_and_dpcr
FLDM: 43.04 (-1.36), A: 42.71 (-0.18), CPHD: 53.14 (-0.78), ILMN: 190.04 (-9.27), QGEN: 24.93 (-0.15)

DexCom Launches CGM App on Apple Watch; Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 12:00PM CDT
DexCom Inc (DXCM) recently announced that its G4 PLATINUM Continuous Glucose Monitoring (CGM) System with Share app will be available on Apple Watch.
ABMD: 69.31 (-0.40), DXCM: 69.28 (-1.05), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04)

AngioDynamics Lags Earnings on Lower Sales, View Tepid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 9:50AM CDT
AngioDynamics Inc. (ANGO) reported unimpressive third-quarter fiscal 2015 results.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), ANGO: 16.75 (-0.04)

Luminex (LMNX) Launches NxTAG RPP for Respiratory Testing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 10:40AM CDT
Luminex Corp. (LMNX) will be introducing the RUO version of the NxTAG RPP in the clinical market.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01)

Inogen Fails 10-K Deadline; Files Form 12b-25 for Extra Time - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 11:40AM CDT
The filing will provide Inogen Inc. (INGN) with an additional 15 calendar days to file its Form 10-K for the year ended Dec 31, 2014.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

Inogen's Texas Facility Ready, Costs Likely to Scale Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:47PM CDT
Inogen Inc (INGN) had decided to lease the Texas facility in December last year for a term of approximately 7 years with the intention of expanding production capacity and lowering the company's average per square foot manufacturing cost.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), EW: 140.87 (+0.39), INGN: 36.39 (-0.04)

Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 25, 10:10AM CDT
Shares of Abiomed Inc (ABMD) scaled a new 52-week high of $74.70 in mid-day trading on Mar 24 after the company announced late Monday that the FDA had approved its Impella 2.5 heart pump.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 11:50AM CDT
Abiomed Inc. (ABMD) recently announced that its Impella 2.5 heart pump has received FDA Pre-Market Approval (PMA) for use in high risk percutaneous coronary intervention (PCI) procedures.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT

DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)

Cantel Medical Beats Q2 Earnings, Provides Positive Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 9:00AM CDT
Cantel Medical Corp (CMN) reported adjusted EPS of 36 cents in the second quarter of fiscal 2015, which beat the Zacks Consensus Estimate by 9 cents
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), CMN: 48.33 (+0.23)

Inogen (INGN) Postpones Q4 Results; Reiterates 2015 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 12:30PM CDT
Inogen Inc (INGN) has postponed its fourth quarter and fiscal 2014 earnings release and will announce results as soon as feasible following the completion of the Audit Committee's investigation.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

'Mad Money' Lightning Round: Buy, Buy, Buy Spirit Airlines
at The Street - Tue Mar 10, 5:00AM CDT
Cramer is concerned about Chicago Bridge & Iron, thinks Ecolab is a terrific stock and wants no part of Telefonica Brasil.
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), TMO: 130.69 (-3.75), FLDM: 43.04 (-1.36), CAMP: 20.87 (+4.19), SRCL: 139.66 (+0.28), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), ECL: 116.05 (+0.17)

Stay Away From Brazilian Stocks - Cramer's Lightning Round (3/9/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Tue Mar 10, 4:26AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, March 9. Bullish Calls: Spirit Airlines (NASDAQ: SAVE ): "You know I like Spirit Air. I like Ben Baldanza and I think they are going to do fine. I...
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), TMO: 130.69 (-3.75), CAMP: 20.87 (+4.19), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), PBR: 8.93 (+0.35), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), FLDM: 43.04 (-1.36), VALE: 6.50 (+0.61), SRCL: 139.66 (+0.28), CODE: 38.59 (+0.47), ECL: 116.05 (+0.17)

Jim Cramer's 'Mad Money' Recap: 6 Years of Market Gains, 10 Years of 'Mad Money'
at The Street - Mon Mar 09, 7:29PM CDT
Cramer celebrates two anniversaries this week: the 'Haines bottom' of six years ago and the debut of his CNBC show.
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), TMO: 130.69 (-3.75), CAMP: 20.87 (+4.19), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), PEP: 97.28 (+0.50), SBUX: 48.33 (-0.04), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), FLDM: 43.04 (-1.36), SRCL: 139.66 (+0.28), AAPL: 128.62 (+1.71), REGN: 472.63 (+9.41), ECL: 116.05 (+0.17)

Symmetry Surgical Posts Loss in Q4, Revenues Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 10:50AM CST
Symmetry Surgical Inc. (SSRG) reported loss of $3.08 per share in the fourth quarter of 2014, which compares unfavorably with the year-ago quarter earnings of 4 cents.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), SSRG: 7.56 (+0.03), LMNX: 16.34 (-0.01)

Teleflex Hits 52-Week High on Strong Q4, Strategic Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:16AM CST
Shares of Teleflex Inc (TFX) scaled a new 52-week high of $123.09 in mid-day trading on Feb 23.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), TFX: 123.02 (+0.27), LMNX: 16.34 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kroger, Imprint Team Up for AI-Driven Mastercard

Kroger Teams Up with Imprint for New Credit Card Kroger’s at it again, folks. They're rolling out a shiny new Mastercard, and it's not just any plastic—it’s powered by the AI-driven platform Imprint. Now, what does this mean for you and me? Well, if you're a frequent flyer at Kroger aisles, you might want to pay attention because this card’s offering point...

Varda Space's Dual Launch Signals Orbital Ambitions

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Concrete Pipe: Foundation of Modern Infrastructure

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Nelson-Jameson Boosts Cold Storage in California Move

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

SaponiQ Reinvents Body Care with Botanical Soap Bars

Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...

Maternal Health Index: A New Tool With Big Ambitions

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...